Articles

Atezolizumab injection (Tecentriq) has been approved by the US Food and Drug Administration for patients with locally advanced or metastatic urothelial carcinoma with disease progression after or ≤12 months of receiving platinum-containing chemotherapy. The recommended dosage of the drug, which is programmed death-ligand 1 blocking antibody, is 1200 mg administered intravenously every 3 weeks until disease progression or unacceptable toxicity. Read More ›

The US Food and Drug Administration has approved nivolumab (Opdivo) for patients with classical Hodgkin Lymphoma that has progressed or relapsed following autologous hematopoietic stem cell transplantation and post-transplant brentuximab vedotin, according to an announcement by the agency. Notably, the intravenous drug was granted accelerated approval, and Breakthrough Therapy Designation. Read More ›

Lenvatinib capsules (Lenvima) have been approved in combination with everolimus in patients with advanced renal cell carcinoma who have had 1 previous anti-angiogenic therapy, according to an announcement by the US Food and Drug Administration. The combination has demonstrated greater progression-free and overall survival rates, compared with lenvatinib monotherapy. Read More ›

The Evolution of the Safe Handling of Hazardous Chemotherapy Drugs

In 1979, Falck and colleagues described the presence of chemotherapy in the urine of nurses caring for patients who had received chemotherapy.1 The discovery that merely handling chemotherapy drugs can lead to absorption of the chemotherapy drugs has been key in the re-evaluation of safety in healthcare environments. In 2004, the National Institute for Occupational Safety and Health (NIOSH) alert noted that skin rashes, infertility, miscarriage, birth defects, and leukemia or other cancers may be associated with working with or near hazardous drugs.2

Read More ›

Advanced nurse practitioner Bridgett Harr, CPN, works at the Cleveland Clinic Foundation, and spoke about her work, and an award-winning study about clinic-based acute rehabilitation for patients led by advanced practice nurses. Read More ›

Women being treated for cancer appear to benefit from a psychological intervention aimed at counseling them on fertility preservation, according to a study reported by the National Comprehensive Cancer Network. Read More ›

The doctoral degree in nursing is earned as either a professional or a practice degree. Nurses with professional doctorates (PhDs) test and validate new knowledge; whereas, nurses with practice doctorates (DNPs) apply concepts into best practices in the clinical setting. Read More ›

The Cancer Support Community (CSC) has developed the Cancer Experience Registry, which is a unique resource that provides evidence-based data about the emotional, social, physical, and financial issues patients and caregivers face. Read More ›

We hope you enjoy this issue, and sincerely look forward to receiving your feedback. Read More ›

Noteworthy Numbers: Melanoma
In recognition of May as Melanoma/Skin Cancer Detection and Prevention Month, and May 27 as the American Cancer Society’s Don’t Fry Day, here are some details about a few types of skin cancer. Read More ›

Page 197 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: